3 recruiting. 3 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Recruiting 3 |
| Phase 2 | 1 | Recruiting 1 |
Follow MCI: new trials by email Literature Review of MCI trials Research Report on MCI
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase I Study of [18F]Flortaucipir PET Imaging in Chinese Subjects: Safety, Pharmacokinetics, Biodistribution, Radiation Dosimetry, and Preliminary Diagnostic Efficacy [18F]Flortaucipir Injection - AD - Alzheimer's Disease, MCI | Phase 1 | Recruiting | Eli Radiopharma | 18 | 2026-04-23 | 2026-05-14 |
| FACE Phase II (a Stage II Trial) Cognitive Remediation, Cognitive Remediation II - MCI, Subjective Cognitive Decline (SCD) | Phase 1 / Phase 2 | Recruiting | Stanford University | 80 | 2025-10-31 | 2026-04-24 |
| Exploring the Utility of [18F]3F4AP for Demyelination Imaging [ 18F]3F4AP, [18F]MK6240, [11C]PIB - Demyelinating Disorders, MCI | Phase 1 | Recruiting | Yale University | 105 | 2025-05-05 | 2026-09-09 |
Alzheimer Disease (2) · Demyelinating Diseases (1) · Multiple Sclerosis (1) · Spinal Cord Injuries (1)
Brain Diseases (2) · Central Nervous System Diseases (2) · Dementia (2) · Mental Disorders (2) · Nervous System Diseases (2) · Neurocognitive Disorders (2) · Neurodegenerative Diseases (2) · Tauopathies (2) · Autoimmune Diseases (1) · Autoimmune Diseases of the Nervous System (1) · Demyelinating Autoimmune Diseases, CNS (1) · Immune System Diseases (1) · Spinal Cord Diseases (1) · Trauma, Nervous System (1) · Wounds and Injuries (1)
2-(4'-(methylamino)phenyl)-6-hydroxybenzothiazole (1) · 7-(6-fluoropyridin-3-yl)-5H-pyrido(4,3-b)indole (1) · Cognitive Remediation (1)
Eli Radiopharma (1) · Stanford University (1) · Yale University (1)
United States (2) · China (1)
Georges El Fakhri, PhD, DABR (1)
P41EB022544 (1), R01AG076153 (1), R01AG085561 (1), R01EB033582 (1)